tiprankstipranks
Archer Materials Limited (AU:AXE)
ASX:AXE
Want to see AU:AXE full AI Analyst Report?

Archer Materials (AXE) AI Stock Analysis

47 Followers

Top Page

AU:AXE

Archer Materials

(Sydney:AXE)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - Gpt-5.6Sol)
Rating:43Neutral
Price Target:
AU$0.19
â–¼(-14.55% Downside)
Action:Reiterated
Date:08/28/26
The score is held down primarily by weak financial performance (revenue collapse, persistent losses, and ongoing negative free cash flow with increased burn) and a bearish technical setup (price below key moving averages and negative MACD). Low debt is a relative positive, but declining equity and assets, along with a negative P/E and no dividend yield data, provide limited support.
Positive Factors
Minimal leverage
Very low debt limits interest and refinancing pressure, preserving more flexibility for research, product development and potential commercialization. This is a durable balance-sheet advantage, although it does not offset the company’s continuing operating cash needs.
Negative Factors
Revenue collapse
The latest revenue collapse shows that commercial activity is not yet dependable, weakening visibility into future funding and scale. Without a sustained revenue base, the company remains reliant on capital or partnerships to advance its technology pipeline.
Read all positive and negative factors
Positive Factors
Negative Factors
Minimal leverage
Very low debt limits interest and refinancing pressure, preserving more flexibility for research, product development and potential commercialization. This is a durable balance-sheet advantage, although it does not offset the company’s continuing operating cash needs.
Read all positive factors

Archer Materials (AXE) vs. iShares MSCI Australia ETF (EWA)

Archer Materials Business Overview & Revenue Model

Company Description
Archer Materials Limited is an Australian technology company dedicated to the advancement and commercialization of semiconductor devices and sophisticated processor chips. Its work primarily targets applications in quantum computing and medical di...
How the Company Makes Money
null...

Archer Materials Financial Statement Overview

Summary
Overall fundamentals are weak. Income statement quality is very poor (revenue collapsed to 0 in 2026 and losses persist), and cash flow is consistently negative with accelerating burn in 2026. The balance sheet is a partial offset due to minimal debt, but equity and assets have declined materially, reducing financial flexibility.
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
24
Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue0.002.06M2.14M1.50M973.00K
Gross Profit-101.15K2.06M2.14M-53.74K922.59K
EBITDA-9.05M-6.94M-5.11M-8.66M-14.97M
Net Income-6.36M-6.97M-4.80M-9.05M-14.12M
Balance Sheet
Total Assets11.87M17.47M22.89M27.21M30.17M
Cash, Cash Equivalents and Short-Term Investments8.44M13.82M18.78M24.19M28.17M
Total Debt0.0014.97K109.31K9.10K19.75K
Total Liabilities1.11M752.16K1.09M1.21M746.23K
Stockholders Equity10.76M16.72M21.80M26.00M29.42M
Cash Flow
Free Cash Flow-5.29M-4.19M-4.99M-3.21M-4.44M
Operating Cash Flow-5.25M-4.19M-4.79M-3.03M-4.30M
Investing Cash Flow4.45M4.11M6.98M2.31M-94.83K
Financing Cash Flow-15.45K-96.30K-115.82K64.90K24.62M

Archer Materials Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.22
Price Trends
50DMA
0.24
Negative
100DMA
0.28
Negative
200DMA
0.32
Negative
Market Momentum
MACD
-0.01
Positive
RSI
40.07
Neutral
STOCH
40.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AXE, the sentiment is Negative. The current price of 0.22 is above the 20-day moving average (MA) of 0.22, below the 50-day MA of 0.24, and below the 200-day MA of 0.32, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 40.07 is Neutral, neither overbought nor oversold. The STOCH value of 40.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AXE.

Archer Materials Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
AU$1.46B-33.79-18.45%―88.62%21.15%
51
Neutral
AU$867.94M-13.68-49.37%―246.45%-30.38%
46
Neutral
AU$57.01M-4.06-96.35%―-25.51%36.03%
44
Neutral
AU$293.05M-8.84-91.74%―48.88%10.59%
43
Neutral
AU$56.76M-8.03-51.46%――8.76%
43
Neutral
AU$18.55M-12.93-21.82%――84.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:AXE
Archer Materials
0.20
-0.07
-25.93%
AU:BRN
BrainChip Holdings
0.13
-0.09
-41.86%
AU:BLG
BluGlass
0.30
0.05
22.92%
AU:4DS
4DS Memory
0.01
-0.02
-64.29%
AU:SLX
Silex Systems Limited
4.80
0.77
19.11%
AU:WBT
Weebit Nano Ltd.
3.46
0.98
39.52%

Archer Materials Corporate Events

Archer Materials Publishes 2026 Corporate Governance Statement
Aug 27, 2026
Archer Materials has released its 2026 Corporate Governance Statement and accompanying Appendix 4G, outlining how the company meets ASX corporate governance requirements for the year ended 30 June 2026. The board highlights that its governance fra...
Archer Materials Narrows Annual Loss but Net Tangible Assets Slide
Aug 27, 2026
Archer Materials reported a net loss of $6.36 million for the year ended 30 June 2026, narrowing from a $6.97 million loss a year earlier, with no dividends declared or paid. The result reflects higher direct expenditure on quantum and biochip tec...
Archer Materials Shareholders Back Equity Resolutions at General Meeting
Aug 18, 2026
Archer Materials Limited has reported that all resolutions put to shareholders at its 18 August 2026 general meeting were passed by poll. The meeting outcomes included strong approval rates across multiple items, reinforcing shareholder support fo...
Archer Materials Advances Potassium Biosensor With Early Blood Collection Study
Aug 13, 2026
Archer Materials has completed an early-stage blood collection study involving 20 donors to support development of its potassium biosensor, identifying a capillary finger-prick method that produced haemolysis levels broadly comparable with standar...
Archer Materials Raises Capital to Advance Quantum Technology Initiatives
Aug 10, 2026
Archer Materials has completed a share purchase plan that raised approximately A$953,000, following a prior A$7 million placement to institutional and sophisticated investors. The new capital will support the implementation of Archer’s strat...
Archer Materials Pushes Biochip Towards Clinical-Ready Point-of-Care Device
Jul 29, 2026
Archer Materials has begun industrial design of its Biochip-based Biosensor device to create a clinically deployable, manufacturable potassium testing system for point-of-care use. The design effort focuses on integrating the validated sensing tec...
Archer Materials Launches Share Purchase Plan to Fund Quantum Expansion
Jul 9, 2026
Archer Materials has dispatched the offer booklet for its share purchase plan, inviting eligible shareholders in Australia and New Zealand to subscribe for up to A$30,000 of new shares at A$0.27 per share, matching the price of a recent placement....
Archer Materials Seeks ASX Quotation for 25.4 Million New Shares
Jul 8, 2026
Archer Materials Limited has applied to the ASX for quotation of 25,407,416 ordinary fully paid shares under its existing issuer code AXE. The new securities, issued on July 9, 2026, form part of previously announced transactions and will expand t...
Archer Materials Advances Quantum Chip and Biochip Programs, Raises Capital for Growth
Jul 8, 2026
Archer Materials reported a strong fourth quarter, highlighting full-wafer manufacturing runs of refined graphene spin qubit designs for its 12CQ quantum chip. This marks progress toward demonstrating a functional qubit and scaling the technology ...
Archer Materials to Brief Investors on IonQ Partnership and Quantum Strategy
Jul 3, 2026
Archer Materials will host a special investor webinar on 7 July 2026 to update shareholders on its strategic partnership with U.S.-listed quantum leader IonQ and to discuss its ongoing Share Purchase Plan offer. The virtual briefing, led by CEO Dr...
Archer Materials Unveils Major Share and Option Issue on ASX
Jul 3, 2026
Archer Materials Limited has outlined plans for a significant equity raising through a combination of a securities purchase plan and placements of ordinary shares and options. The proposed issue includes tens of millions of new ordinary fully paid...
Archer Materials outlines capital raising push for quantum partnership with IonQ
Jul 3, 2026
Archer Materials has outlined a capital raising presentation in July 2026 centred on a strategic compute and capability partnership with U.S.-listed quantum computing firm IonQ. The initiative is framed as part of the company’s effort to bri...
Archer raises A$7m, launches SPP to fund IonQ quantum deal
Jul 3, 2026
Archer Materials has secured binding commitments for a two‑tranche equity placement raising A$7 million and launched a share purchase plan of up to A$3 million at A$0.27 per share, supported by institutional and sophisticated investors as we...
Archer strikes IonQ deal to boost sovereign quantum ambitions
Jul 1, 2026
Archer Materials has signed a strategic Quantum Compute Agreement with U.S.-listed IonQ, giving it access to IonQ’s Quantum Cloud and specialist engineering support to develop quantum algorithms and applications. The partnership positions Ar...
Archer Materials Requests Trading Halt Ahead of Capital Raising
Jul 1, 2026
Archer Materials has requested a trading halt on its ASX-listed securities as it prepares to announce a material capital raising, prompting ASX Compliance to suspend trading until the news is released or normal trading resumes on 3 July 2026. The ...
Archer Materials Lapses 57,286 Performance Rights After Unmet Conditions
Jun 26, 2026
Archer Materials Limited has announced the lapse of 57,286 performance rights, which have ceased because the conditions attached to these rights were not met or could no longer be satisfied. The cessation of these securities reflects an adjustment...
Archer Marks Quantum Milestone in Fraud Detection Push
Jun 4, 2026
Archer Materials has completed the latest phase of its quantum machine learning fraud detection project, successfully developing and benchmarking a quantum neural network model on a large, publicly available financial transaction dataset. The mode...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 28, 2026